Serial brain 18FDG-PET in anti-AMPA receptor limbic encephalitis

Journal of Neuroimmunology

Volumn 271, Issue 1-2, 2014, Pages 53-55

  Spatola, Marianna ^a   Stojanova, Vesna ^a   Prior, John O ^a   Dalmau, Josep ^b,c   Rossetti, Andrea O ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biomarker; Complementary exam; Disease activity; Follow up; Therapy

Indexed keywords

AMPA RECEPTOR ANTIBODY; CYCLOPHOSPHAMIDE; ETIRACETAM; FLUORODEOXYGLUCOSE F 18; GLUCOSE; METHYLPREDNISOLONE; PREDNISONE; PREGABALIN; PROTEIN; RECEPTOR ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG; AMPA RECEPTOR; AUTOANTIBODY; BIOLOGICAL MARKER; DIAGNOSTIC AGENT;

ADULT; AMNESIA; ANTICONVULSANT THERAPY; ARTICLE; BRAIN ATROPHY; BRAIN EDEMA; BRAIN METABOLISM; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DRUG SUBSTITUTION; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; EPISODIC MEMORY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLUCOSE HYPERMETABOLISM; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; IMMUNOTHERAPY; LEARNING; MULTIPLE CYCLE TREATMENT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY HALLUCINATION; PARANEOPLASTIC NEUROPATHY; PERIODIC LATERALIZED EPILEPTIFORM DISCHARGE; PLASMAPHERESIS; PLEOCYTOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECALL; RECOGNITION; SEIZURE; SEMANTICS; TONIC CLONIC SEIZURE; (18)FDG PET; BRAIN; COMPLEMENTARY EXAM; DISEASE ACTIVITY; FOLLOW-UP; IMMUNOLOGY; METABOLISM; PATHOLOGY; SCINTISCANNING; THERAPY;

(18)FDG PET; BIOMARKER; COMPLEMENTARY EXAM; DISEASE ACTIVITY; FOLLOW-UP; THERAPY;

ADULT; AUTOANTIBODIES; BRAIN; ELECTROENCEPHALOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIMBIC ENCEPHALITIS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, AMPA;

EID: 84900491772     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.04.002     Document Type: Article

References (10)

1. Ances B.M., Vitaliani R., Taylor R.A., Liebeskind D.S., Voloschin A., Houghton D.J., Galetta S.L., Dichter M., Alavi A., Rosenfeld M.R., Dalmau J. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005, 128:1764-1777.
2. Chong D.J., Hirsch L.J. Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns. J. Clin. Neurophysiol. 2005, 22:79-91.
3. Irani S.R., Stagg C.J., Schott J.M., Rosenthal C.R., Schneider S.A., Pettingill P., Pettingill R., Waters P., Thomas A., Voets N.L., Cardoso M.J., Cash D.M., Manning E.N., Lang B., Smith S.J., Vincent A., Johnson M.R. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 2013, 136:3151-3162.
4. Kröll-Seger J., Bien C.G., Huppertz H.J. Non-paraneoplastic limbic encephalitis associated with antibodies to potassium channels leading to bilateral hippocampal sclerosis in a pre-pubertal girl. Epileptic Disord. 2009, 11:54-59.
5. Lai M., Hughes E.G., Peng X., Zhou L., Gleichman A.J., Shu H., Matà S., Kremens D., Vitaliani R., Geschwind M.D., Bataller L., Kalb R.G., Davis R., Graus F., Lynch D.R., Balice-Gordon R., Dalmau J. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann. Neurol. 2009, 65:424-434.
6. Lancaster E., Martinez-Hernandez E., Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011, 77:179-189.
7. Lee B.Y., Newberg A.B., Liebeskind D.S., Kung J., Alavi A. FDG-PET findings in patients with suspected encephalitis. Clin. Nucl. Med. 2004, 29:620-625.
8. Sharma A., Dubey D., Sawhney A., Janga K. GAD65 positive autoimmune limbic encephalitis: a case report and review of literature. J. Clin. Med. Res. 2012, 4:424-428.
9. Titulaer M.J., McCracken L., Gabilondo I., Armangué T., Glaser C., Iizuka T., Honig L.S., Benseler S.M., Kawachi I., Martinez-Hernandez E., Aguilar E., Gresa-Arribas N., Ryan-Florance N., Torrents A., Saiz A., Rosenfeld M.R., Balice-Gordon R., Graus F., Dalmau J. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013, 12:157-165.
10. Urbach H., Soeder B.M., Jeub M., Klockgether T., Meyer B., Bien C.G. Serial MRI of limbic encephalitis. Neuroradiology 2006, 48:380-386.